Institutional Ownership Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX). We have compiled data on the 37 institutions that hold shares in the stock, with a total of 3.1 Million shares, which have been reported (via 13F filing form) to have a value of $6.25 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
David Einhorn
Greenlight Capital Inc | New York, Ny
|
Feb 14, 2024 Q4 2023 |
588,410
shares
|
$1.12 Million
0.1% of portfolio
|
Q4 2023
Added 7.66%
|
|
Dme Capital Management, LP
New York, NY |
May 15, 2025 Q1 2025 |
566,130
shares
|
$1.08 Million
0.05% of portfolio
|
Q1 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
282,211
shares
|
$536,200
0.0% of portfolio
|
Q1 2025
Added 5.53%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
254,990
shares
|
$484,481
0.0% of portfolio
|
Q1 2025
Added 44.0%
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
196,026
shares
|
$372,449
0.0% of portfolio
|
Q1 2025
Added 113.68%
|
|
Joel Greenblatt
Gotham Asset Management, LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
153,984
shares
|
$292,569
0.0% of portfolio
|
Q1 2025
Reduced 2.64%
|
|
Dauntless Investment Group, LLC
Commerce Township, MI |
May 07, 2025 Q1 2025 |
125,584
shares
|
$238,609
0.28% of portfolio
|
Q1 2025
New holding
|
|
Telemetry Investments, L.L.C.
New York, NY |
Feb 14, 2023 Q4 2022 |
123,000
shares
|
$233,700
0.61% of portfolio
|
Q4 2022
Reduced 18.0%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
100,170
shares
|
$190,323
0.0% of portfolio
|
Q1 2025
Added 18.42%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
99,795
shares
|
$189,610
0.0% of portfolio
|
Q1 2025
Added 12.75%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
85,958
shares
|
$163,320
0.0% of portfolio
|
Q1 2025
Added 83.23%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
84,620
shares
|
$160,778
0.0% of portfolio
|
Q2 2024
Added 12.23%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
71,137
shares
|
$135,160
0.0% of portfolio
|
Q4 2024
Added 106.57%
|
|
Cambridge Investment Research Advisors, Inc.
|
Apr 22, 2025 Q1 2025 |
59,500
shares
|
$113,050
0.0% of portfolio
|
Q1 2025
Added 9.17%
|
|
Kovitz Investment Group Partners, LLC
|
May 19, 2025 Q1 2025 |
47,578
shares
|
$90,398
0.0% of portfolio
|
Q1 2025
New holding
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
43,360
shares
|
$82,384
0.0% of portfolio
|
Q1 2025
Added 23.09%
|
|
Prelude Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
35,820
shares
|
$68,058
0.01% of portfolio
|
Q1 2024
Reduced 38.35%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2025 Q1 2025 |
30,004
shares
|
$57,007
0.0% of portfolio
|
Q4 2024
New holding
|
|
Quadrature Capital LTD
London, X0 |
May 13, 2025 Q1 2025 |
20,154
shares
|
$38,292
0.0% of portfolio
|
Q1 2025
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
19,019
shares
|
$36,136
0.0% of portfolio
|
Q1 2025
Added 63.79%
|
|
Benedict Financial Advisors Inc
|
May 07, 2025 Q1 2025 |
18,000
shares
|
$34,200
0.01% of portfolio
|
Q1 2025
Added 12.5%
|
|
Sandhill Capital Partners LLC
Buffalo, NY |
May 14, 2025 Q1 2025 |
15,400
shares
|
$29,260
0.0% of portfolio
|
Q3 2024
New holding
|
|
Two Sigma Securities, LLC
New York, NY |
May 15, 2025 Q1 2025 |
14,355
shares
|
$27,274
0.0% of portfolio
|
Q1 2025
New holding
|
|
Sprott Inc.
Toronto, A6 |
May 14, 2025 Q1 2025 |
14,000
shares
|
$26,600
0.0% of portfolio
|
Q4 2024
New holding
|
|
Armis Advisers, LLC
Atlanta, GA |
May 08, 2025 Q1 2025 |
10,750
shares
|
$20,425
0.0% of portfolio
|
Q1 2025
New holding
|